It depends on how strong the data is. If we smash
Post# of 148050
If we meet the p value I expect EUA followed by a phase 4 trial.
If we miss PE but show clinical significance, I would expect CYDY to build a case for EUA, but may take longer.
Where it goes from there is hard to predict, but fun to try.